date,title,source
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-17-18,MIT researchers among winners of prestigious Breakthrough Prize,American City Business Journals
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-18-18,Biogen to Present Data from Alzheimers Disease Portfolio at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Meeting,GlobeNewswire
Oct-19-18,Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?,Zacks
Oct-19-18,Alkermes Boasts Strong Portfolio and Impressive Pipeline,Zacks
Oct-19-18,"Stocks making the biggest move premarket: PG, HON, F, VFC, HOG AMZN & more",CNBC
Oct-22-18,Biogen earnings: Its all about upcoming Alzheimers disease results,MarketWatch
Oct-22-18,Biogen Q3 Earnings Outlook,Benzinga
Oct-22-18,"Analysts wary of Biogen's strategy as earnings, Alzheimer's data loom",American City Business Journals
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,Biogen on Deck as Biotechs Face Make-or-Break Earnings Season,Bloomberg
Oct-23-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-23-18,Biogen Inc (BIIB) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-23-18,Biogen Earnings: 10 Highlights From BIIBs Q3,InvestorPlace
Oct-23-18,"Stocks - Caterpillar, 3M Tank in Pre-market; McDonalds, Verizon Gain",Investing.com
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,"Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines",Zacks
Oct-23-18,Biogen stock rises 3% after Q3 profit and revenue beats,MarketWatch
Oct-23-18,"Biogen Inc Earnings, Revenue beat in Q3",Investing.com
Oct-23-18,Biogen (BIIB) Q3 Earnings & Sales Beat Estimates,Zacks
Oct-23-18,[$$] Biogen 3Q Profit Rises 18%,The Wall Street Journal
Oct-23-18,"Biogen, UCB study of lupus treatment fails primary endpoint",MarketWatch
Oct-23-18,Biogen third-quarter profit rises 17.8 pct,Reuters
Oct-23-18,"Stoke CEO weighs clinical trials, IPO and partnerships after $90M round",American City Business Journals
Oct-23-18,UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus,GlobeNewswire
Oct-24-18,Biogen Rides the Spinraza Wave to Double-Digit Growth,Motley Fool
Oct-24-18,Alkermes Makes Financial Progress as Its Pipeline Moves Forward,Motley Fool
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-25-18,Biogen Stock Dips After Alzheimer's Results Show 'Thin' Impact,Investor's Business Daily
Oct-25-18,This experimental Alzheimers disease drug seemed promising  before the latest results left many unsure,MarketWatch
Oct-25-18,"Eisai, Biogen Alzheimer's data fails to convince skeptics",Reuters
Oct-25-18,Biogen analysts pounce on 'thin' Alzheimer's trial data,American City Business Journals
Oct-25-18,Biogen shares slip after Alzheimer's data fails to convince,Reuters
Oct-25-18,Biogen/Eisai Alzheimer's data suggests treatment effect related to drug,Reuters
Oct-25-18,Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimers Disease at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Conference,GlobeNewswire
Oct-25-18,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",Benzinga
Oct-26-18,This experimental Alzheimers disease drug seemed promising  before the latest results left many unsure,MarketWatch
Oct-26-18,The October stock crash has wiped out $45.5B from Mass. health firms,American City Business Journals
Oct-26-18,"Top Research Reports for McDonald's, Thermo Fisher & Caterpillar",Zacks
Oct-26-18,Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimers Disease (CTAD),GlobeNewswire
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Biogen And Eisai May Be At Odds In Alzheimer's  So What Now?,Investor's Business Daily
Oct-29-18,"New Research Coverage Highlights Rite Aid, The Boeing, Cabot, Biogen, McDonald's, and Pegasystems  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-31-18,Sarissa Capitals Alex Denner Bullish on Biogen (BIIB),Insider Monkey
Nov-01-18,Biotech ETFs in Focus on String of Q3 Earnings Beat,Zacks
Nov-05-18,Biogen Stock Rebounds After Impressive Q3 Earnings,InvestorPlace
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-07-18,7 Healthcare Stocks Soaring on Election Results,InvestorPlace
Nov-08-18,Jeff Auxier Comments on Biogen,GuruFocus.com
Nov-08-18,Jeff Auxier's Auxier Asset Management 3rd Quarter Commentary,GuruFocus.com
Nov-08-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-09-18,6 Pharmaceutical Stocks to Buy After the Midterms,InvestorPlace
Nov-09-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-12-18,An expensive new medication is finally available for her rare disease  but shes been fighting for two years to get it,MarketWatch
Nov-12-18,Ionis Pharmaceuticals Collects Royalties -- and Spends It All,Motley Fool
Nov-13-18,An expensive new medication is finally available for her rare disease  but shes been fighting for two years to get it,MarketWatch
Nov-14-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-14-18,[$$] Possible delisting of BioLogics threatens Samsungs growth strategy,Financial Times
Nov-21-18,Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?,Zacks
Nov-23-18,US benefits manager baulks after Novartis values gene therapy at $4-5 mln,Reuters
Nov-23-18,Why Biogen Inc (NASDAQ:BIIB) Looks Like A Quality Company,Simply Wall St.
Nov-23-18,U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million,Reuters
Nov-26-18,Hedge Funds Are Crazy About Biogen Inc. (NASDAQ:BIIB),Insider Monkey
Nov-27-18,Health Care Stocks May Be Safe Haven in Event of Market Downturn,GuruFocus.com
Nov-29-18,How To Trade Growth Stocks: Why Biogen Fell Below Its Buy Point On Breakout Day But Still Won Big,Investor's Business Daily
Nov-29-18,Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma,Zacks
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Dec-03-18,AbbVie Presents Long-Term Data on Cancer Drugs at ASH 2018,Zacks
Dec-04-18,FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101,Zacks
Dec-06-18,Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data,GlobeNewswire
Dec-11-18,4 Biotech Stocks Investors Can Add to Their Portfolio in 2019,Zacks
Dec-12-18,5 Pharma Stocks That Could Cure Ailing Portfolios in 2019,InvestorPlace
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-12-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen",Zacks
Dec-13-18,Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge?,Benzinga
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-13-18,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",Benzinga
Dec-14-18,5 Incredible ETFs & Stocks to Buy on the Dip,Zacks
Dec-14-18,5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019,Zacks
Dec-17-18,Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU,Zacks
Dec-17-18,Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis,GlobeNewswire
Dec-18-18,Biogen's Slump Is Likely to Continue,TheStreet.com
Dec-18-18,Biotech Stocks Gilead Sciences and Biogen Have Room to Bounce Back,Barrons.com
Dec-18-18,"Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug",Zacks
